What is Goodbody Health Inc?
Goodbody Health Limited provides various health checks and tests in the United Kingdom.
GDBYF · Verdict
Solid reward · elevated risk
GDBYF stands out on valuation and balance sheet, but watch the volatility signal.
Based on 88% data coverage
GDBYF · Verdict
P/E 3.7×
Current ratio 2.03
Weak vs peers
-14% net margin · -56% ROE
9% free-cash-flow margin
Model-based scoring. For information only — not financial advice.
Goodbody Health Limited provides various health checks and tests in the United Kingdom. The company offers women's health tests, including menopause, female hormones, AMH fertility, pregnancy, and PCOS blood tests, as well as advanced well-woman tests; men's health tests, such as male hormones, erectile dysfunction, and testosterone blood tests, as well as advanced well-man tests; prostate cancer tests; and prenatal blood tests comprising prenatal paternity, early baby gender blood, and various prenatalsafe NIPT blood tests. The company is listed on the OTCQB in USA, operating in the Healthcare sector, with a market capitalisation of 529.00.
The scoring profile indicates moderate reward potential, with valuation and growth as the leading contributors. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.
For informational purposes only. Not financial advice.